Acurx Pharmaceuticals, Inc. — Director's Dealing 2021

Jun 25, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Acurx Pharmaceuticals, Inc. (ACXP)
CIK: 0001736243
Period of Report: 2021-06-24

Reporting Person: LUCI DAVID P (Director, President and CEO, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1003523	Direct
Common Stock	15083	Indirect
Common Stock	35000	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants for Common Stock	$2.00	2028-03-20	Common Stock (6250)		Direct
Warrants for Common Stock	$3.00	2028-10-23	Common Stock (7500)		Direct
Warrants for Common Stock	$4.00	2029-03-29	Common Stock (3125)		Direct

Footnotes

F1: Reflects the conversion of membership interests to common stock pursuant to the corporate conversion of Acurx Pharmaceuticals, Inc.